138 related articles for article (PubMed ID: 38291201)
1. Influence of copper(I) nicotinate complex on the Notch1 signaling pathway in triple negative breast cancer cell lines.
Abdel-Mohsen MA; Badawy AM; Abu-Youssef MA; Yehia MA; Abou Shamaa LD; Mohamed SA
Sci Rep; 2024 Jan; 14(1):2522. PubMed ID: 38291201
[TBL] [Abstract][Full Text] [Related]
2. Influence of copper (I) nicotinate complex and autophagy modulation on doxorubicin-induced cytotoxicity in HCC1806 breast cancer cells.
Abdel-Mohsen MA; Abdel Malak CA; El-Shafey ES
Adv Med Sci; 2019 Mar; 64(1):202-209. PubMed ID: 30798072
[TBL] [Abstract][Full Text] [Related]
3. Antitumor Activity of Copper (I)-Nicotinate Complex and Autophagy Modulation in HCC1806 Breast Cancer Cells.
Abdel-Mohsen MA; Abdel Malak CA; Abou Yossef MA; El-Shafey ES
Anticancer Agents Med Chem; 2017 Nov; 17(11):1526-1536. PubMed ID: 28356017
[TBL] [Abstract][Full Text] [Related]
4. Oncostatic treatment effect of triple negative breast cancer cell line with copper (I)-nicotinate complex.
Abdel-Mohsen MA; Toson EA; Helal MA
J Cell Biochem; 2019 Mar; 120(3):4278-4290. PubMed ID: 30362603
[TBL] [Abstract][Full Text] [Related]
5. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells.
Zeng D; Liang YK; Xiao YS; Wei XL; Lin HY; Wu Y; Bai JW; Chen M; Zhang GJ
Int J Cancer; 2020 Jul; 147(2):490-504. PubMed ID: 32020593
[TBL] [Abstract][Full Text] [Related]
7. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
8. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.
Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY
Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769
[TBL] [Abstract][Full Text] [Related]
9. Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression.
Siddharth S; Parida S; Muniraj N; Hercules S; Lim D; Nagalingam A; Wang C; Gyorffy B; Daniel JM; Sharma D
Elife; 2021 Dec; 10():. PubMed ID: 34889737
[TBL] [Abstract][Full Text] [Related]
10. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
Xie X; Kaoud TS; Edupuganti R; Zhang T; Kogawa T; Zhao Y; Chauhan GB; Giannoukos DN; Qi Y; Tripathy D; Wang J; Gray NS; Dalby KN; Bartholomeusz C; Ueno NT
Oncogene; 2017 May; 36(18):2599-2608. PubMed ID: 27941886
[TBL] [Abstract][Full Text] [Related]
11. Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes.
Alkaraki A; Alshaer W; Wehaibi S; Gharaibeh L; Abuarqoub D; Alqudah DA; Al-Azzawi H; Zureigat H; Souleiman M; Awidi A
Breast Cancer; 2020 Sep; 27(5):989-998. PubMed ID: 32328816
[TBL] [Abstract][Full Text] [Related]
12. Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer.
Li W; Yang H; Li X; Han L; Xu N; Shi A
Oncol Rep; 2019 Jan; 41(1):437-446. PubMed ID: 30365081
[TBL] [Abstract][Full Text] [Related]
13. miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer.
Kong P; Chen L; Yu M; Tao J; Liu J; Wang Y; Pan H; Zhou W; Wang S
Cell Death Dis; 2018 Oct; 9(11):1059. PubMed ID: 30333478
[TBL] [Abstract][Full Text] [Related]
14. Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis.
Smoots SG; Schreiber AR; Jackson MM; Bagby SM; Dominguez ATA; Dus ED; Binns CA; MacBeth M; Whitty PA; Diamond JR; Pitts TM
Breast Cancer Res; 2024 Mar; 26(1):35. PubMed ID: 38429789
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.
Adinew GM; Messeha SS; Taka E; Badisa RB; Antonie LM; Soliman KFA
Nutrients; 2022 May; 14(10):. PubMed ID: 35631261
[TBL] [Abstract][Full Text] [Related]
16. Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins.
Zhang M; Meng M; Liu Y; Qi J; Zhao Z; Qiao Y; Hu Y; Lu W; Zhou Z; Xu P; Zhou Q
Breast Cancer Res; 2021 Dec; 23(1):116. PubMed ID: 34922602
[TBL] [Abstract][Full Text] [Related]
17. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.
Wang X; Chen T; Li C; Li W; Zhou X; Li Y; Luo D; Zhang N; Chen B; Wang L; Zhao W; Fu S; Yang Q
J Hematol Oncol; 2022 Aug; 15(1):122. PubMed ID: 36038948
[TBL] [Abstract][Full Text] [Related]
18. Interference KRT17 reverses doxorubicin resistance in triple-negative breast cancer cells by Wnt/β-catenin signaling pathway.
Wu L; Ding W; Wang X; Li X; Yang J
Genes Genomics; 2023 Oct; 45(10):1329-1338. PubMed ID: 37634232
[TBL] [Abstract][Full Text] [Related]
19. OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis.
Wu M; Huang Q; Liao M; Wu X; Xi H; Ma H; Li S; Zhang Y; Xia Y
Cell Oncol (Dordr); 2022 Dec; 45(6):1255-1275. PubMed ID: 36155886
[TBL] [Abstract][Full Text] [Related]
20. Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity-An Isobolographic Analysis.
Wawruszak A; Luszczki JJ; Kalafut J; Okla K; Halasa M; Rivero-Muller A; Stepulak A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
